Press Releases

Date Title and Summary
Toggle Summary First Hospitals in the World Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
iDMS™ Data Management System Helps Improve Treatment Outcomes and Efficiency by Sharing Patient Data Throughout the Entire Disease Management Period SUNNYVALE, Calif. , Dec. 14, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the Heidelberg University Hospital in
Toggle Summary Accuray Military Veterans Support U.S. Veteran Community
Advanced Radiation Therapy Systems Manufactured, Installed and Serviced by Accuray Veterans Help Improve the Lives of Military Personnel who are Diagnosed with Cancer SUNNYVALE, Calif. , Nov. 8, 2017 /PRNewswire/ -- November 11, 2017 marks Veterans Day in the United States , a day to publicly
Toggle Summary Treatment Planning for the CyberKnife® System Now Up to 40% Faster
- Accuray Precision™ Treatment Planning System and CyberKnife System Software Upgrade Enhances Efficiency and Ease-of-Use - Leading Radiation Oncology Providers at Institut Gustave Roussy, Lynn Cancer Institute, Multicare Hospital, Queen Elizabeth Hospital Birmingham, University Clinic for
Toggle Summary Accuray Generated $55.6 Million in First Quarter Gross Orders; Revenue Increased 5 Percent Year over Year
SUNNYVALE, Calif. , Oct. 24, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first fiscal quarter ended September 30, 2017 . First Quarter Highlights Gross orders increased 11 percent to $55.6 million , net orders were $51.0 million .
Toggle Summary European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy® System
SUNNYVALE, Calif. , Oct. 19, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the Accuray TomoTherapy® System by University Hospital of Tours (CHU).
Toggle Summary Accuray To Report Fiscal 2018 First Quarter Financial Results On October 24, 2017
SUNNYVALE, Calif. , Oct. 10, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2017 on Tuesday, October 24, 2017 after the market close.  Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
Toggle Summary Accuray Incorporated Reports Inducement Grant Under NASDAQ Listing Rules
SUNNYVALE, Calif. , Oct. 4, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, an equity inducement award to Shig Hamamatsu , the company's new VP, Finance & Chief Accounting Officer. As a material inducement to Mr.
Toggle Summary 10-year Data Shows CyberKnife® System Provides Excellent Long-term Control of Low-Risk Prostate Cancer
First Study to Evaluate the Use of Stereotactic Body Radiation Therapy in Low-Risk Prostate Cancer 10 Years Post Treatment SUNNYVALE, Calif. , Sept. 26, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective study of 230 men with low-risk prostate
Toggle Summary Accuray Showcases CyberKnife® and Radixact™ Systems at ASTRO 2017
SUNNYVALE, Calif. , Sept. 20, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that data and first-hand experience with its advanced CyberKnife® and Radixact™ Systems , and unique software solutions, will be shared by leading radiation oncology practitioners at the 2017
Toggle Summary Accuray Reports Fourth Quarter and Fiscal 2017 Financial Results
SUNNYVALE, Calif. , Aug. 22, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2017 . Q4 Fiscal 2017 and Recent Highlights Gross orders of $85.7 million driven by strong demand from both the new Radixact